139 related articles for article (PubMed ID: 35422393)
1. Categorization and comparisons of drug recalls for manufacturers and compounders.
Mattingly AN; Mattingly TJ; Nguyen Phan AL; Negash K
J Am Pharm Assoc (2003); 2022; 62(4):1344-1350. PubMed ID: 35422393
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of FDA drug recalls: A 30-month analysis.
Hall K; Stewart T; Chang J; Freeman MK
Am J Health Syst Pharm; 2016 Feb; 73(4):235-40. PubMed ID: 26843501
[TBL] [Abstract][Full Text] [Related]
3. A four-year assessment of the characteristics of Rwandan FDA drug recalls.
Bahizi M; Nyirimigabo E; Ntirenganya L; Umuhoza MI; Habyalimana V; Bikorimana G; Ukwishaka J
BMC Public Health; 2024 Jul; 24(1):1784. PubMed ID: 38965502
[TBL] [Abstract][Full Text] [Related]
4. Blood product recalls in the United States.
McCullough J; Riley E; Lindgren B; Pulkrabek S; Hall R; Riley W
Transfusion; 2014 Sep; 54(9):2276-82. PubMed ID: 24863173
[TBL] [Abstract][Full Text] [Related]
5. Twenty-Two Years of U.S. Meat and Poultry Product Recalls: Implications for Food Safety and Food Waste.
Gorton A; Stasiewicz MJ
J Food Prot; 2017 Apr; 80(4):674-684. PubMed ID: 28294687
[TBL] [Abstract][Full Text] [Related]
6. A retrospective regulatory analysis of FDA recalls carried out by pharmaceutical companies from 2012 to 2023.
Patel R; Vhora A; Jain D; Patel R; Khunt D; Patel R; Dyawanapelly S; Junnuthula V
Drug Discov Today; 2024 Jun; 29(6):103993. PubMed ID: 38670257
[TBL] [Abstract][Full Text] [Related]
7. Human Medicines Recall Announcements in Saudi Arabia Between 2017 and 2022: An Analysis of Saudi Food and Drug Authority (SFDA) Reports.
Almutairi M; Algabbani A; Alasiri A; Alhomaidan A; Alqahtani AS
Ther Innov Regul Sci; 2024 Jul; 58(4):689-695. PubMed ID: 38546962
[TBL] [Abstract][Full Text] [Related]
8. Drug and medical device product failures and the stability of the pharmaceutical supply chain.
Livingston AN; Mattingly TJ
J Am Pharm Assoc (2003); 2021; 61(1):e119-e122. PubMed ID: 32753251
[TBL] [Abstract][Full Text] [Related]
9. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
Peters W; Pellerin C; Janney C
Biomed Instrum Technol; 2020 Nov; 54(6):418-426. PubMed ID: 33339030
[TBL] [Abstract][Full Text] [Related]
10. Medical Device Recalls in Radiation Oncology: Analysis of US Food and Drug Administration Data, 2002-2015.
Connor MJ; Tringale K; Moiseenko V; Marshall DC; Moore K; Cervino L; Atwood T; Brown D; Mundt AJ; Pawlicki T; Recht A; Hattangadi-Gluth JA
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):438-446. PubMed ID: 28463163
[TBL] [Abstract][Full Text] [Related]
11. Overview of Class I Device Recalls in Diagnostic Radiology, 2002-2015.
Ghobadi CW; Hayman EL; Xu S
J Am Coll Radiol; 2016 Jun; 13(6):638-43. PubMed ID: 26922597
[TBL] [Abstract][Full Text] [Related]
12. Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety.
Janetos TM; Ghobadi CW; Xu S; Walter JR
Am J Obstet Gynecol; 2017 Jul; 217(1):42-46.e1. PubMed ID: 28500861
[TBL] [Abstract][Full Text] [Related]
13. Use of Recalled Devices in New Device Authorizations Under the US Food and Drug Administration's 510(k) Pathway and Risk of Subsequent Recalls.
Kadakia KT; Dhruva SS; Caraballo C; Ross JS; Krumholz HM
JAMA; 2023 Jan; 329(2):136-143. PubMed ID: 36625810
[TBL] [Abstract][Full Text] [Related]
14. FDA recalls: how do pacemaker manufacturers compare?
Tyers GF
Ann Thorac Surg; 1989 Sep; 48(3):390-6. PubMed ID: 2774725
[TBL] [Abstract][Full Text] [Related]
15. The nature and pattern of coronary stent recalls.
Kumar S; Innasimuthu AL; Marmur JD
J Invasive Cardiol; 2014 Sep; 26(9):433-6. PubMed ID: 25198486
[TBL] [Abstract][Full Text] [Related]
16. Substandard and falsified medical product recalls in Zambia from 2018 to 2021 and implications on the quality surveillance systems.
Chabalenge B; Jere E; Nanyangwe N; Hikaambo C; Mudenda S; Banda M; Kalungia A; Matafwali S
J Med Access; 2022; 6():27550834221141767. PubMed ID: 36601496
[TBL] [Abstract][Full Text] [Related]
17. Recalls of foods containing undeclared allergens reported to the US Food and Drug Administration, fiscal year 1999.
Vierk K; Falci K; Wolyniak C; Klontz KC
J Allergy Clin Immunol; 2002 Jun; 109(6):1022-6. PubMed ID: 12063535
[TBL] [Abstract][Full Text] [Related]
18. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
Everhart AO; Sen S; Stern AD; Zhu Y; Karaca-Mandic P
JAMA; 2023 Jan; 329(2):144-156. PubMed ID: 36625811
[TBL] [Abstract][Full Text] [Related]
19. Overview of high-risk Food and Drug Administration recalls for cosmetics and personal care products from 2002 to 2016.
Janetos TM; Akintilo L; Xu S
J Cosmet Dermatol; 2019 Oct; 18(5):1361-1365. PubMed ID: 30565865
[TBL] [Abstract][Full Text] [Related]
20. The Identification of Quality Risk Factors for Non-biological Complex Drugs and Epilepsy Drugs Using Statistical Analysis of Formulation-Based Recalls in the USA.
Kerstiens EA; Byrn SR; Clase KL
AAPS PharmSciTech; 2021 Dec; 23(1):19. PubMed ID: 34904204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
